In Vitro Validation of a Closed Device Enabling the Purification of the Fluid Portion of Liposuction Aspirates
Authors:
- Claudia CicioneCCClaudia Cicione
- Giuseppe Di TarantoGTGiuseppe Di Taranto
- Marta BarbaMBMarta Barba
- Maria A. IsgròMIMaria A. Isgrò
- Alessio D’alessioADAlessio D’alessio
- Daniele CervelliDCDaniele Cervelli
- Fabio V. SciarrettaFSFabio V. Sciarretta
- Sandro PeloSPSandro Pelo
- Fabrizio MichettiFMFabrizio Michetti
- Wanda LattanziWLWanda Lattanzi
- 1 April 2016
- journal article
- research article
- Published by Wolters Kluwer Health in Plastic and Reconstructive Surgery
- Vol. 137 (4) , 1157-1167
Abstract
Adipose tissue harvested through lipoaspiration is widely exploited in plastic and cosmetic surgery, because of its remarkable trophic properties, especially relying on the presence of adipose-derived stem cells. The common procedures for adipose-derived stem cell isolation are mainly based on tissue fractionation and enzymatic digestion, requiring multiple hours of uninterrupted work, unsuitable for direct surgical applications. Recent studies demonstrated the feasibility of isolating adipose stromal cells without the need for enzymatic digestion. These studies reported the processing of the fluid portion of liposuctioned adipose tissue (lipoaspirate fluid), which contains a significant amount of progenitor cells endowed with plastic and trophic features. In this article, the authors introduce a brand new closed device--the MyStem EVO kit--which allows nonenzymatic tissue separation and rapid isolation of lipoaspirate fluid from human liposuctioned adipose tissue. Adipose tissue was liposuctioned from 14 donors, split into aliquots, and alternatively processed using either centrifugation or the MyStem EVO kit, to separate fatty and lipoaspirate fluid portions. The samples were analyzed comparatively by flow cytometry, histology, and differentiation assays. Osteoinductive and angioinductive features were analyzed through in vitro co-culture assays. The alternative procedures enabled comparable yields; the kit rapidly isolated lipoaspirate fluid comprising a homogenous cell population with adipose stem cell immunophenotype, bilineage potential, and efficient osteoinductive and angioinductive features. MyStem EVO allows the rapid isolation of lipoaspirate fluid with trophic properties within a closed system, and is potentially useful for regenerative medicine applications.Keywords
This publication has 54 references indexed in Scilit:
- One-Step Surgical Procedure for the Treatment of Osteochondral Defects with Adipose-Derived Stem Cells in a Caprine Knee Defect: A Pilot StudyBioResearch Open Access, 2013
- Lim Mineralization Protein 3 Induces the Osteogenic Differentiation of Human Amniotic Fluid Stromal Cells through Kruppel-Like Factor-4 Downregulation and Further Bone-Specific Gene ExpressionJournal of Biomedicine and Biotechnology, 2012
- Stromal Vascular Fraction Transplantation as an Alternative Therapy for Ischemic Heart Failure: Anti-inflammatory RoleJournal of Cardiothoracic Surgery, 2011
- Ex vivo-transduced autologous skin fibroblasts expressing human Lim mineralization protein-3 efficiently form new bone in animal modelsGene Therapy, 2008
- Adult stem cells and their trans-differentiation potential—perspectives and therapeutic applicationsJournal of Molecular Medicine, 2008
- Adipose-derived stem cells: Isolation, expansion and differentiation☆Methods, 2008
- Cell-Assisted Lipotransfer: Supportive Use of Human Adipose-Derived Cells for Soft Tissue Augmentation with LipoinjectionTissue Engineering, 2006
- Characterization of freshly isolated and cultured cells derived from the fatty and fluid portions of liposuction aspiratesJournal of Cellular Physiology, 2006
- Cell Surface and Transcriptional Characterization of Human Adipose‐Derived Adherent Stromal (hADAS) CellsStem Cells, 2005
- Multilineage Cells from Human Adipose Tissue: Implications for Cell-Based TherapiesTissue Engineering, 2001